Overview

Blind and Ultrasound Guided Injection in Morton Neuroma

Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this work trial is to compare the effectiveness of blind and ultrasound guided injection for Morton neuroma in order to determine which is more appropriate as the initial procedure in conservative treatment
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Complejo Hospitalario Universitario de Granada
Treatments:
Mepivacaine
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- Clinical suspicion of Morton neuroma confirmed in ultrasound scan

- Symptoms present more than six months

- The thickness of the nerve must be at least 2 mm in short axis and at least 5 mm in
the longitudinal axis.

Exclusion Criteria:

- Contraindication for the use of corticosteroids or local anesthetics

- Presence of inflammatory arthropathy or neuropathy

- Skin lesions in the area

- diabetes mellitus

- Infiltration or previous surgery in the area

- Refusal to participate in the study